At this time, generic Daliresp (roflumilast) is not available. The brand-name medication is currently protected by an unexpired patent and possibly exclusivity rights. When these expire, a generic version could be introduced. However, other circumstances, such as lawsuits or other patents, may further delay the manufacturing of a generic version of the drug.
Interested in a Discount on Daliresp?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Enter Your Email Address
Thank you!Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
Daliresp™ (roflumilast) is a prescription medication used to treat chronic obstructive pulmonary disease (COPD). It is the first approved medication in a group of drugs known as phosphodiesterase type-4 (PDE4) inhibitors.
Daliresp is made by Nycomed GmbH for Forest Pharmaceuticals, Inc. It is protected by exclusivity rights that prevent a generic version from being manufactured in the United States.
The first patent for Daliresp is currently set to expire in January 2015, although the drug may also be protected from generic competition by certain exclusivity rights (which are different from patents) that are set to expire in February 2016. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Daliresp uses or lawsuits.
No -- roflumilast is the active ingredient in Daliresp, but is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a drug, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.